Dimethylthiourea inhibition of B16 melanoma growth and induction of phenotypic alterations; Relationship to ATP levels
1991

Effects of Dimethylthiourea on Melanoma Cells

publication Evidence: moderate

Author Information

Author(s): A. Fux, Y. Sidi, G. Kessler-Icekson, L. Wasserman, A. Novogrodsky, J. Nordenberg

Primary Institution: Rogoff Medical Research Institute; Department Medicine D, Beilinson Medical Center, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Israel.

Hypothesis

Decreased ATP content might be involved in mediating the effects of DMTU on B16 melanoma cell growth and phenotypic expression.

Conclusion

The study suggests that DMTU treatment leads to decreased ATP levels, which may contribute to the inhibition of melanoma cell growth and induction of phenotypic changes.

Supporting Evidence

  • DMTU significantly decreased ATP content in B16 melanoma cells.
  • DMTU treatment led to increased lactate levels in the cells.
  • Cells resistant to DMTU showed higher ATP levels and were not affected by DMTU treatment.

Takeaway

DMTU is a chemical that can slow down the growth of melanoma cells by lowering their energy levels.

Methodology

The study involved treating B16 melanoma cells with DMTU and measuring changes in ATP content, lactate levels, and enzyme activities.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication